Glowing Threats: The Bioluminescent Bacterium Behind Marine Disease MiDOG Animal Diagnostics

February 5, 2025

Key takeaways:

Vibrio harveyi is a bioluminescent bacterial pathogen of marine fish, crustaceans, and mollusks.
The disease symptoms are indistinct, and the bacterium’s growth is slow, complicating traditional culture-based diagnostic techniques.
Next Generation Sequencing (NGS) provides fast and accurate diagnosis of harveyi from infected animals and contaminated water, allowing for early detection and disease control.

Vibrio harveyi is a Gram-negative bacterium that is part of the Vibrio genus, a group of bacteria known for their aquatic habitats. It is characterized by its motility, as it is a highly mobile organism equipped with a polar flagellum, allowing it to move efficiently through liquid environments. V. harveyi is facultatively anaerobic, meaning it can thrive in both aerobic and anaerobic conditions, though it prefers oxygen-rich environments. The bacterium has a distinctive bioluminescent feature, producing light due to a set of genes involved in its quorum-sensing system which allows the bacteria to emit a bioluminescent signal when the population has grown sufficiently (Defoirdt et al., 2008). This makes it an interesting organism for study in microbial ecology, where it plays a role in bacterial communication and virulence in aquatic ecosystems. V. harveyi is typically found in marine environments, particularly in the waters surrounding coastal regions where it can infect a range of marine organisms. The bacterium’s ability to cause disease in both wild and farmed aquatic animals makes it a significant concern in the field of veterinary medicine, especially in aquaculture, where it can lead to severe losses.

Host Range and Symptoms of Disease

harveyi primarily affects marine organisms but can also infect other aquatic species, leading to various health complications. The bacterium’s host range includes a variety of species, primarily marine fish and crustaceans, where it causes diseases that often result in severe economic losses. This bacterium affects animals in the wild and in controlled aquaculture environments, making it a major concern for fish farming industries (Austin & Zhang, 2006).

Marine Fish: Infected fish exhibit symptoms such as lethargy, loss of appetite, skin lesions, and in severe cases, death. The disease can lead to a condition known as “vibriosis,” characterized by hemorrhagic septicemia, which can affect the internal organs (Zhang & Austin, 2000).
Shrimp: V. harveyi infections in shrimp can result in “black gill disease,” where the gills turn black, the shrimp exhibit reduced feeding, and there is a significant decrease in growth rate. The infection can also lead to high mortality rates (Karunasagar et al., 2005).
Mollusks: Oysters, clams, and other mollusks can suffer from mass mortalities when infected with V. harveyi. Symptoms include shell discoloration, tissue necrosis, and softening of the shells.
Crustaceans: Beyond shrimp, other crustaceans can develop signs of infection such as abnormal swimming behavior, body discoloration, and reduced reproductive success.

Treatments for Vibrio harveyi

Treating V. harveyi infections in aquaculture is critical for minimizing economic losses. While treatment approaches are available, it is often a combination of antibiotics, good husbandry practices, and environmental management that can help control the spread of the bacterium. Antibiotic use must be approached carefully to avoid resistance development (Alderman & Hastings, 1998).

Oxytetracycline: A commonly used antibiotic, effective in treating a wide range of Vibrio species, including V. harveyi. It is administered in feed or water.
Amoxicillin: This antibiotic can be used to treat infections in fish, particularly in the early stages of the disease.
Enrofloxacin: A fluoroquinolone antibiotic effective against V. harveyi, often used in aquaculture to manage bacterial outbreaks.
Chloramphenicol: Sometimes used in veterinary medicine for treating infections in fish and crustaceans.
Furazolidone: This drug can be employed as an antimicrobial agent for managing Vibrio infections, especially in aquaculture settings.

In addition to antibiotics, controlling the water quality, minimizing stressors, and practicing proper farm hygiene are key strategies to prevent the spread of this pathogenic bacterium in aquaculture environments.

Challenges in Diagnosing Vibrio harveyi

Diagnosing V. harveyi infections can be challenging due to the bacterium’s diverse ecological range and the clinical similarity of its symptoms to other bacterial infections. Traditional diagnostic methods such as culture-based techniques may take several days to yield results and can be affected by the presence of other microorganisms in the environment, complicating the interpretation of results. Additionally, the bacterium’s ability to exist in both pathogenic and non-pathogenic forms means that detection of V. harveyi in the environment or infected hosts does not always correlate with disease, making clinical diagnosis more complex.

**Role of Next Generation Sequencing in Vibrio harveyi diagnosis**

To overcome these challenges, Next Generation Sequencing (NGS) has emerged as a powerful tool. NGS allows comprehensive, high-throughput analysis of the genetic material from infected samples, enabling the precise identification of V. harveyi strains, including those that may be difficult to isolate using traditional methods. NGS can also be used to detect V. harveyi in contaminated water samples to provide faster diagnosis and control of the disease before infection occurs (Thaithongnum et al., 2006). Furthermore, NGS can provide insights into the genetic markers associated with virulence and antibiotic resistance, facilitating better-targeted treatments and more effective disease management strategies in aquaculture settings. This advanced technology helps to overcome the limitations of traditional diagnostic methods, enabling quicker and more accurate detection of V. harveyi infections.

Conclusion

Vibrio harveyi is a fascinating yet harmful bacterium that plays a significant role in both the natural marine ecosystem and aquaculture industries. Its bioluminescent abilities make it an intriguing subject of study, but its potential to cause disease in marine life, including fish, shrimp, and mollusks, has serious economic implications. As the bacterium continues to pose challenges for diagnosis and treatment, innovative methods like Next Generation Sequencing offer promise for more accurate identification, early detection and targeted management. By understanding its ecology, host range, and the available treatment options, aquaculture professionals can better protect their stocks from the devastating effects of V. harveyi. Vigilant monitoring, effective management practices, and the judicious use of antibiotics will remain essential in combating this glowing yet dangerous pathogen.

References:

Alderman, D. J., & Hastings, T. S. (1998). Antibiotic use in aquaculture: Development of antibiotic resistance—potential for consumer health risks. International Journal of Food Science & Technology, 33(2), 139-155. DOI: https://doi.org/10.1046/j.1365-2621.1998.3320139.x
Austin, B., & Zhang, X. H. (2006). Vibrio harveyi: A significant pathogen of marine vertebrates and invertebrates. Letters in Applied Microbiology, 43(2), 119-124. DOI: https://doi.org/10.1111/j.1472-765X.2006.01989.x
Defoirdt, T., Boon, N., Sorgeloos, P., Verstraete, W., & Bossier, P. (2008). Quorum sensing and quorum quenching in Vibrio harveyi: lessons learned from in vivo work. The ISME journal, 2(1), 19-26. DOI: https://doi.org/10.1038/ismej.2007.92
Karunasagar, I., Pai, R., Malathi, G. R., & Karunasagar, I. (2005). Mass mortality of Penaeus monodon larvae due to antibiotic-resistant Vibrio harveyi Aquaculture, 128(3-4), 203-209. DOI: https://doi.org/10.1016/0044-8486(94)90309-3
Thaithongnum, S., Ratanama, P., Weeradechapol, K., Sukhoom, A., & Vuddhakul, V. (2006). Detection of V. harveyi in shrimp postlarvae and hatchery tank water by the Most Probable Number technique with PCR. Aquaculture, 261(1), 1-9. DOI: https://doi.org/10.1016/j.aquaculture.2006.07.001
Zhang, X. H., & Austin, B. (2000). Pathogenicity of Vibrio harveyi to salmonids. Journal of fish diseases, 23(2), 93-102. DOI: https://doi.org/10.1046/j.1365-2761.2000.00214.x

Categories: Bacterial Infections, Fish, Next-Gen DNA Sequencing Technology, Skin Health

Validated by Veterinarians

“Clients expect their veterinarians to stay up to date on all matters that affect the health and well being of their non-human family members. The current technique that we have used to determine the presence and antibiotic sensitivity of organisms causing disease in our pets is over a century old.

With the emergence of dangerous antibacterial resistance, it is critical that veterinarians are able to offer laser focused diagnostics and treatment. MiDog enables us to offer care that exceeds the typical standard of care.”

Bernadine Cruz, DVM, Laguna Hills Animal Hospital Laguna Woods, CA

“I love the absolute abundance and comparing the fungal with bacterial infection. I do not worry as much about getting a false negative urinary infection reading as I do with traditional urine cultures. Several times the same urine would culture negative but MiDOG would detect pathogens.”

Michael Morgan, DVMQuail Animal Hospital, Tustin, CA

“The MiDOG All-in-One Test is amazing, I would use it instead of culture and sensitivity. Such rapid and detailed results, I will reach for MiDOG before culture next time!

Thank you very much MiDOG, for sharing the opportunity to try your technology.”

Martha Smith-Blackmore, DVM, President of Forensic Veterinary Investigations, LLC – Boston, MA

“The MiDOG All-in-One Microbial Test is our new gold standard of pathogen identification. The results are so accurate and valuable – especially with assessing both bacterial and fungal infections with the same sample.

Thank you MiDOG!”

Kathy Wentworth, DVM, Diplomate ABVP Canine and Feline Practice – PetPoint Medical Center, Irvine, CA

“The MiDOG staff was extremely helpful and supportive.”

Cathy Curtis, DVM – London, UK

“I have had great results using the MiDOG® Test. Compared to traditional culture tests, I am better able to target the treatment for dogs because the MiDOG® Test is so sensitive that it identifies all pathogens including bacteria and fungi, as well as antibiotic sensitivity.

The cost and turnaround time are about the same as a culture test, but I get much more data. The test has great performance and I believe the NGS technology will be a game changer for veterinarians treating dogs with lesions or other infections.”

Michael Kavanagh, DVM, Practice owner – Saddleback Animal Hospital, Tustin, CA

“It’s helpful to have an NGS spectrum because it gives you a broader insight of what’s happening and what might be going on.”

Richard Harvey BVSc DVD DipECVD PhD FRSB FRCVS – European Specialist in Veterinary Dermatology – Head of Dermatology, Willows Veterinary Centre & Referral Service – Solihull, England UK

“I have been using MiDog for over 4 years now and exclusively as my test of choice for all cultures for 3 years. It is so great to submit a culture and feel confident there will be a result when it comes back, especially for urine cultures. The reports were intimidating at first because they contain so much information. After the first few, I am now quickly able to glance over it and pick out the highlights. I can then come back later and pour over all the details. I have been extremely pleased with my patients’ results using the test as well. I don’t envision ever going back to traditional culture and susceptibilities again.”

Brian M. Urmson, DVM, Columbiana Veterinary Associates

“As an exotic veterinarian, there are numerous tests we have to consider to check specific bacterial and fungal organisms based on the species. MiDOG eliminates the need for many of these separate samples and provides definitive results quickly to help us treat our patients more efficiently and effectively. The lab is wonderful to work with and has never rejected our samples- they even processed a lizard toe we amputated and determined the cause of skin infection.”

Dr. Melissa Giese, Chicago Exotics Animal Hospital

“MiDOG’s diagnostic approach offers the unique ability to identify pathogens that evade traditional culture and sensitivity testing. I have found that adding a molecular based testing approach in the form of Next Generation Sequencing (NGS) from MiDOG to my routine diagnostic cultures can be extremely helpful in the identification and diagnosis of uncommon pathogens in veterinary medicine.”

Dr. Wayne Rosenkrantz, Animal Dermatology Clinic – Tustin

“She [Dr. Krumbeck] really did a great job of making complicated concepts accessible and demonstrating the value of your services. I’m really looking forward to working with MiDOG on my research project!”

Dr. Yaicha Peters, Animal Dermatology Clinic – San Diego

“As a proud collaborator with MiDOG, I deeply appreciate their dedication to fostering partnerships between industry and veterinary experts. Their commitment to enhancing diagnostic quality for veterinarians is commendable. In my experience, their support has been invaluable, earning them a ‘Double A+, Triple Star’ rating. Their assistance has been faultless, contributing significantly to the success of my projects and studies. I eagerly anticipate our continued collaboration.”

Dr. Richard Harvey, BVSc DVD DipECVD PhD FRSB FRCVS; European Specialist in Veterinary Dermatology

“We’re seeing that, if we prescribe too many antibiotics or they’re taken too frequently, animals are developing inappropriate or pathogenic strains of bacteria. We’re also seeing that our antibiotics are just not working against them anymore… It’s a good example of why we need better diagnostic testing, like MiDOG, so that we’re selecting the correct antibiotic every time our patients have an infection.”

Dr. Alissa Rexo, DVM, CVA, DACVD, Mid-Atlantic Veterinary Dermatology

“The NGS technique as offered by MiDOG is wonderful because pathogens like Melissococcus plutonius, for example, are difficult to grow and keep alive in the laboratory. A standard laboratory cannot truly examine or even properly diagnose this pathogen in bee hives at this time. But with NGS, we can reliably diagnose it.”

Dr. Joerg Mayer, Entomologist and Microbiologist at the University of Georgia

“For me, as a clinician and as a researcher, I see the immense value in the product [the All-in-One Test]. I have had great success using MiDOG clinically, including identifying Mycoplasma in a 24 year old pigeon, a Nannizziopsis spp in a ball python from a large pet distributor, Mycoplasma and Fusobacterium necrophorum co-infection in a peacock, and to identify an abnormal gut GI in a technician’s dog that tested negative for everything else (but we were able to establish what was abnormal, and work toward fixing it).”

Dr. Jeremy Rayl – Veterinarian, Block House Creek Animal Hospital, Cedar Park, Texas

“With MiDog results I not only receive a list of organisms detected in the sample, but also cell counts which allow me to target the most abundant pathogens or the most pathogenic. The identification of antimicrobial resistance genes is also helpful in selecting an appropriate antibiotic. Another benefit is that sample handling is less prone to risk of overgrowth and is stable at room temperature. Easy and informative. A great tool in our diagnostic toolbox!!”

Lauren Palmer DVM, MPH, Marine mammal Care Center Los Angeles

“If every rescue and sanctuary could run a scan on new admissions, I think it would open everyone’s eyes. These birds have been through so much and damaged by human pathogens. Plus the MiDog test was much more affordable than a battery of PCRs, several c&s, repeated tests, etc. AND non-invasive. Thank you. I would advise every sanctuary and other parrot facility to run MiDOG screening. I know it might reveal more than we want to know.”

Patricia Latas, DVM, Wild Parrot Coalition